Trial ID or NCT#

NCT01449279

Status

NOT RECRUITING

Purpose

To determine the safety of local palliative radiation therapy used in combination with anti-CTLA-4 immunotherapy.

Official Title

A Pilot Study of Ipilimumab in Subjects With Stage IV Melanoma Receiving Palliative Radiation Therapy

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Susan Knox
Radiation oncologist
Associate Professor of Radiation Oncology
Sunil Reddy
Medical oncologist, Cutaneous oncology specialist
Clinical Assistant Professor, Medicine - Oncology
Susan M. Swetter, MD
Dermatologist, Dermatologic oncologist, Cutaneous oncology specialist, Melanoma specialist
Professor of Dermatology at Palo Alto Veterans Affairs Health Care System and the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Chuck Di Bari
(650) 498-4073